VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,785 | -15.5% | 549,406 | -5.4% | 0.07% | -13.8% |
Q2 2023 | $17,490 | -20.4% | 580,857 | -14.5% | 0.08% | -25.9% |
Q1 2023 | $21,976 | +37.0% | 679,308 | +21.4% | 0.11% | +30.1% |
Q4 2022 | $16,038 | -99.9% | 559,609 | -7.2% | 0.08% | +1.2% |
Q3 2022 | $14,538,000 | +34.7% | 602,731 | +52.9% | 0.08% | +41.4% |
Q2 2022 | $10,796,000 | -46.8% | 394,294 | -25.5% | 0.06% | -37.6% |
Q1 2022 | $20,287,000 | +75.3% | 529,008 | +46.4% | 0.09% | +78.8% |
Q4 2021 | $11,572,000 | -1.1% | 361,274 | -9.0% | 0.05% | -10.3% |
Q3 2021 | $11,695,000 | -49.1% | 396,834 | -41.3% | 0.06% | -47.3% |
Q2 2021 | $22,985,000 | +17.4% | 676,428 | +12.3% | 0.11% | +3.8% |
Q1 2021 | $19,582,000 | +7.8% | 602,537 | +19.5% | 0.11% | 0.0% |
Q4 2020 | $18,160,000 | -39.3% | 504,167 | -34.0% | 0.11% | -47.5% |
Q3 2020 | $29,920,000 | +28.4% | 764,036 | +20.2% | 0.20% | +15.4% |
Q2 2020 | $23,311,000 | +229.7% | 635,525 | +107.1% | 0.18% | +157.4% |
Q1 2020 | $7,070,000 | -19.9% | 306,878 | +1.8% | 0.07% | 0.0% |
Q4 2019 | $8,829,000 | +5.7% | 301,529 | -3.6% | 0.07% | -6.8% |
Q3 2019 | $8,356,000 | +45.0% | 312,845 | +38.8% | 0.07% | +37.7% |
Q2 2019 | $5,762,000 | -30.2% | 225,427 | -38.7% | 0.05% | -32.9% |
Q1 2019 | $8,251,000 | -2.6% | 368,002 | -8.4% | 0.08% | -16.0% |
Q4 2018 | $8,475,000 | +42.7% | 401,843 | +25.3% | 0.09% | +64.9% |
Q3 2018 | $5,938,000 | -9.5% | 320,610 | +9.0% | 0.06% | -17.4% |
Q2 2018 | $6,560,000 | +0.3% | 294,052 | -1.2% | 0.07% | -6.8% |
Q1 2018 | $6,539,000 | +3.2% | 297,513 | +9.1% | 0.07% | -1.3% |
Q4 2017 | $6,337,000 | +21.2% | 272,656 | +19.8% | 0.08% | +7.1% |
Q3 2017 | $5,227,000 | -20.8% | 227,648 | -23.8% | 0.07% | -27.8% |
Q2 2017 | $6,599,000 | +17.8% | 298,878 | +21.7% | 0.10% | +1.0% |
Q1 2017 | $5,602,000 | +115.5% | 245,600 | +97.6% | 0.10% | +95.9% |
Q4 2016 | $2,600,000 | -46.4% | 124,286 | -32.3% | 0.05% | -45.6% |
Q3 2016 | $4,852,000 | +2.0% | 183,584 | +6.9% | 0.09% | -10.9% |
Q2 2016 | $4,758,000 | – | 171,691 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |